Eldred Rock Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.79M | Buy |
80,882
+47
| +0.1% | +$5.69K | 2.97% | 19 |
|
|
2025
Q1 | $9.03M | Buy |
80,835
+20,184
| +33% | +$2.26M | 2.76% | 23 |
|
|
2024
Q4 | $5.9M | Buy |
60,651
+108
| +0.2% | +$10.5K | 2.03% | 26 |
|
|
2024
Q3 | $6.96M | Buy |
60,543
+32,816
| +118% | +$3.77M | 2.33% | 27 |
|
|
2024
Q2 | $2.95M | Buy |
27,727
+13,348
| +93% | +$1.42M | 1.23% | 26 |
|
|
2024
Q1 | $1.39M | Buy |
14,379
+588
| +4% | +$56.9K | 0.76% | 24 |
|
|
2023
Q4 | $1.39M | Buy |
+13,791
| New | +$1.39M | 0.89% | 22 |
|